{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:12:32Z","timestamp":1778829152985,"version":"3.51.4"},"reference-count":35,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec id=\"st1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cushing\u2019s disease (CD) is a rare endocrine disorder associated with significant morbidity and increased mortality if left untreated. Endoscopic transsphenoidal surgery (ETSS) is the preferred first-line treatment; however, reported remission and recurrence rates vary widely due to differences in biochemical remission criteria and follow-up duration. This study aimed to evaluate surgical outcomes, remission rates using standard and strict biochemical criteria, recurrence, and postoperative complications following ETSS for CD at a tertiary referral center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective analysis included 82 patients with confirmed CD who underwent ETSS between January 2015 and July 2025. Diagnosis was established using standard biochemical tests, with inferior petrosal sinus sampling where clinically indicated. Postoperative remission was assessed using two criteria: (1) standard remission \u2013 early morning serum cortisol &lt;138 nmol\/L within 7 days of surgery and (2) strict remission \u2013 postoperative day-3 serum cortisol &lt;50 nmol\/L. Patients with persistent hypercortisolism were managed with early repeat ETSS, radiotherapy, or medical therapy. Postoperative complications, endocrine deficits, and recurrence were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The cohort comprised 58 females and 24 males, with a median age of 33.6 years (range 14\u201371). Preoperative MRI identified microadenomas in 64 patients and macroadenomas in 18 patients. Using standard criteria, remission after initial ETSS was achieved in 70 of 82 patients (85.4%), increasing to 90.2% (74\/82) after inclusion of early repeat ETSS. Using strict criteria, early biochemical remission was observed in 56 patients (68.3%) following initial surgery. Persistent hypercortisolism was noted in 12 patients (14.6%), of whom six underwent early repeat ETSS, achieving remission in 66% by standard criteria. Transient diabetes insipidus (DI) occurred in 26.8% and permanent DI in 9.8% of patients. No cases of cerebrospinal fluid leak, meningitis, vascular injury, or postoperative visual deterioration were observed. During short-term follow-up, recurrence was documented in two patients, both with macroadenomas. Median follow-up duration was 4 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st4\">\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>ETSS provides high remission rates with minimal surgical morbidity in patients with CD. Remission rates are significantly influenced by the biochemical criteria applied, with higher rates observed using standard Endocrine Society definitions compared to stricter postoperative cortisol thresholds. Microadenomas demonstrate superior surgical outcomes. While early biochemical remission rates were high, the relatively short median follow-up limits assessment of long-term recurrence and durability of remission, underscoring the need for extended surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/sni_172_2026","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:48:30Z","timestamp":1778827710000},"page":"293","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of endoscopic transsphenoidal pituitary surgery in patients with Cushing\u2019s disease: A retrospective review"],"prefix":"10.25259","volume":"17","author":[{"given":"Vartika","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"10.25259\/SNI_172_2026\/ref-1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11102-006-9276-2","article-title":"Disorders of water metabolism following transsphenoidal pituitary surgery: A single-institution experience","volume":"9","author":"Adams","year":"2006","journal-title":"Pituitary"},{"key":"10.25259\/SNI_172_2026\/ref-2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/jnnp-2012-303194","article-title":"Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: A systematic review and meta-analysis","volume":"84","author":"Ammirati","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.25259\/SNI_172_2026\/ref-3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.2005.02380.x","article-title":"Long-term remission rates after pituitary surgery for Cushing\u2019s disease: The need for long-term surveillance","volume":"63","author":"Atkinson","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.25259\/SNI_172_2026\/ref-4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10143-011-0365-y","article-title":"Prognostic factors of visual field improvement after transsphenoidal surgery for pituitary macroadenomas: Review of the literature and quantitative analysis","volume":"35","author":"Barzaghi","year":"2012","journal-title":"Neurosurg Rev"},{"key":"10.25259\/SNI_172_2026\/ref-5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10143-013-0506-6","article-title":"Early promising results for the endoscopic surgical treatment of Cushing\u2019s disease","volume":"37","author":"Berker","year":"2014","journal-title":"Neurosurg Rev"},{"key":"10.25259\/SNI_172_2026\/ref-6","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing\u2019s syndrome: A consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.25259\/SNI_172_2026\/ref-7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing\u2019s syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.25259\/SNI_172_2026\/ref-8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12902-021-00679-9","article-title":"Outcomes of endoscopic transsphenoidal surgery for Cushing\u2019s disease","volume":"21","author":"Brady","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"10.25259\/SNI_172_2026\/ref-9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s11102-018-0893-3","article-title":"Endoscopic vs. microscopic transsphenoidal surgery for Cushing\u2019s disease: A systematic review and meta-analysis","volume":"21","author":"Broersen","year":"2018","journal-title":"Pituitary"},{"key":"10.25259\/SNI_172_2026\/ref-10","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00701-017-3140-1","article-title":"Efficacy of endoscopic endonasal transsphenoidal surgery for Cushing\u2019s disease in 230 patients with positive and negative MRI","volume":"159","author":"Cebula","year":"2017","journal-title":"Acta Neurochir (Wien)"},{"key":"10.25259\/SNI_172_2026\/ref-11","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/foc.2007.23.3.11","article-title":"Current state of the art in the diagnosis and surgical treatment of Cushing disease: Early experience with a purely endoscopic endonasal technique","volume":"23","author":"Dehdashti","year":"2007","journal-title":"Neurosurg Focus"},{"key":"10.25259\/SNI_172_2026\/ref-12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/014107688607900504","article-title":"Transsphenoidal surgery for Cushing\u2019s disease","volume":"79","author":"Fahlbusch","year":"1986","journal-title":"J R Soc Med"},{"key":"10.25259\/SNI_172_2026\/ref-13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/cen.13866","article-title":"Diagnosis and management of central diabetes insipidus in adults","volume":"90","author":"Garrahy","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.25259\/SNI_172_2026\/ref-14","doi-asserted-by":"crossref","first-page":"972617","DOI":"10.1155\/2012\/972617","article-title":"Diagnosing growth hormone deficiency in adults","volume":"2012","author":"Glynn","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.25259\/SNI_172_2026\/ref-15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3171\/jns.1997.87.1.0044","article-title":"Endoscopic endonasal transsphenoidal surgery: Experience with 50 patients","volume":"87","author":"Jho","year":"1997","journal-title":"J Neurosurg"},{"key":"10.25259\/SNI_172_2026\/ref-16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/2230-8210.86974","article-title":"Cushing\u2019s syndrome: A stepwise approach to diagnosis","volume":"15","author":"Lila","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"10.25259\/SNI_172_2026\/ref-17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.wneu.2016.02.059","article-title":"Complications related to the endoscopic endonasal transsphenoidal approach for nonfunctioning pituitary macroadenomas in 300 consecutive patients","volume":"89","author":"Magro","year":"2016","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_172_2026\/ref-18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11102-012-0437-1","article-title":"Single-surgeon fully endoscopic endonasal transsphenoidal surgery: Outcomes in three-hundred consecutive cases","volume":"16","author":"Mamelak","year":"2013","journal-title":"Pituitary"},{"key":"10.25259\/SNI_172_2026\/ref-19","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3171\/2017.6.JNS17635","article-title":"Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing\u2019s disease: Implications for immediate reoperation and remission","volume":"129","author":"Mayberg","year":"2018","journal-title":"J Neurosurg"},{"key":"10.25259\/SNI_172_2026\/ref-20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.1996.614436.x","article-title":"Assessment of cure after transsphenoidal surgery for Cushing\u2019s disease","volume":"44","author":"McCance","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.25259\/SNI_172_2026\/ref-21","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1227\/01.NEU.0000159647.64275.9D","article-title":"Results of transsphenoidal surgery in a large series of patients with pituitary adenoma","volume":"56","author":"Mortini","year":"2005","journal-title":"Neurosurgery"},{"key":"10.25259\/SNI_172_2026\/ref-22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3171\/jns.2005.103.3.0448","article-title":"Predictors of diabetes insipidus after transsphenoidal surgery: A review of 881 patients","volume":"103","author":"Nemergut","year":"2005","journal-title":"J Neurosurg"},{"key":"10.25259\/SNI_172_2026\/ref-23","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s syndrome: An endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.25259\/SNI_172_2026\/ref-24","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3390\/jcm8111951","article-title":"Cushing\u2019s disease","volume":"8","author":"Nishioka","year":"2019","journal-title":"J Clin Med"},{"key":"10.25259\/SNI_172_2026\/ref-25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1012905415868","article-title":"Current management of prolactinomas","volume":"54","author":"Nomikos","year":"2001","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_172_2026\/ref-26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jc.2007-2013","article-title":"Late recurrences of Cushing\u2019s disease after initially successful transsphenoidal surgery","volume":"93","author":"Patil","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.25259\/SNI_172_2026\/ref-27","doi-asserted-by":"crossref","first-page":"R227","DOI":"10.1530\/EJE-14-0883","article-title":"Therapy of endocrine disease: outcomes in patients with Cushing\u2019s disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence","volume":"172","author":"Petersenn","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.25259\/SNI_172_2026\/ref-28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00701-015-2638-7","article-title":"Pure endoscopic transsphenoidal surgery for functional pituitary adenomas: Outcomes in Cushing\u2019s disease","volume":"158","author":"Sarkar","year":"2016","journal-title":"Acta Neurochir (Wien)"},{"key":"10.25259\/SNI_172_2026\/ref-29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bmj.298.6665.2","article-title":"Postoperative diabetes insipidus","volume":"298","author":"Seckl","year":"1989","journal-title":"BMJ"},{"key":"10.25259\/SNI_172_2026\/ref-30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11102-015-0645-6","article-title":"Comorbidities in Cushing\u2019s disease","volume":"18","author":"Sharma","year":"2015","journal-title":"Pituitary"},{"key":"10.25259\/SNI_172_2026\/ref-31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1227\/NEU.0b013e31827b966a","article-title":"Pure endoscopic transsphenoidal surgery for Cushing\u2019s disease: Techniques, outcomes, and predictors of remission","volume":"72","author":"Starke","year":"2013","journal-title":"Neurosurgery"},{"key":"10.25259\/SNI_172_2026\/ref-32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1530\/EJE-10-1120","article-title":"Comparisons in epidemiology, diagnostic features, and cure rates between pediatric-and adult-onset Cushing\u2019s disease","volume":"164","author":"Storr","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.25259\/SNI_172_2026\/ref-33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2265.1993.tb00975.x","article-title":"Transsphenoidal resection in Cushing\u2019s disease: Undetectable serum cortisol as the definition of successful treatment","volume":"38","author":"Trainer","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.25259\/SNI_172_2026\/ref-34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/EJE-13-0325","article-title":"Endoscopic transsphenoidal pituitary surgery: A good and safe primary treatment option for Cushing\u2019s disease, even in case of macroadenomas or invasive adenomas","volume":"169","author":"Wagenmakers","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.25259\/SNI_172_2026\/ref-35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.0300-0664.2001.01444.x","article-title":"Undetectable postoperative cortisol does not always predict long-term remission in Cushing\u2019s disease","volume":"56","author":"Yap","year":"2002","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/outcomes-of-endoscopic-transsphenoidal-pituitary-surgery-in-patients-with-cushings-disease-a-retrospective-review\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/outcomes-of-endoscopic-transsphenoidal-pituitary-surgery-in-patients-with-cushings-disease-a-retrospective-review\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:48:36Z","timestamp":1778827716000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/outcomes-of-endoscopic-transsphenoidal-pituitary-surgery-in-patients-with-cushings-disease-a-retrospective-review\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":35,"alternative-id":["10.25259\/SNI_172_2026"],"URL":"https:\/\/doi.org\/10.25259\/sni_172_2026","relation":{},"ISSN":["2152-7806","2229-5097"],"issn-type":[{"value":"2152-7806","type":"electronic"},{"value":"2229-5097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"293"}}